Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2009
05/13/2009EP2058323A1 Tumour-associated peptides which bind to MHC molecules
05/13/2009EP2058005A1 Inoculant for treating coeliac disease and method for producing the inoculant, application of a peptide sequence joined with a bacterial toxin for activating the immune system against prolamine and designer peptide
05/13/2009EP2058004A1 Mannose immunogens for HIV-1
05/13/2009EP2057996A2 Y4 selective receptor agonists for therapeutic intervention
05/13/2009EP2057466A2 Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy
05/13/2009EP2057270A1 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins
05/13/2009EP2057266A1 Genetic remodeling in bifidobacterium
05/13/2009EP2057195A2 Pharmaceutical composition for suppression of apoptosis and method for delivering the same
05/13/2009EP2057194A2 Engineered anti-il-23r antibodies
05/13/2009EP2057189A1 Acylated exendin-4 compounds
05/13/2009EP2057188A2 Dpp-iv resistant gip hybrid polypeptides with selectable properties
05/13/2009EP2057187A2 Genes and polypeptides relating to breast cancers
05/13/2009EP2057186A2 Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying hpv antigens
05/13/2009EP2056880A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation
05/13/2009EP2056868A1 Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein
05/13/2009EP2056860A2 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof
05/13/2009EP2056853A1 Combination therapy
05/13/2009EP2056852A2 Bmp-7 variant compositions, methods and uses
05/13/2009EP2056838A2 Combination therapy for treatment of immune disorders
05/13/2009EP1924136A4 Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp
05/13/2009EP1913024B1 METHOD FOR THE PURIFICATION OF ALPHA-1 PROTEINASE INHIBITOR (a1PI)
05/13/2009EP1848804A4 Anti-muci alpha beta antibodies
05/13/2009EP1824875A4 Plant proteins having an abscisic acid binding site and methods of use
05/13/2009EP1812470B1 Cyclization of a peptide
05/13/2009EP1485477B1 Novel type-1 cytokine receptor glm-r
05/13/2009EP1485407B1 A mutated immunoglobulin-binding protein
05/13/2009EP1466174B1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
05/13/2009EP1373525B1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof
05/13/2009EP1350109B1 Marker for inflammatory conditions
05/13/2009EP1320540B1 Peptidomimetic protease inhibitors
05/13/2009EP1317536B1 Tnf receptor-like molecules and uses thereof
05/13/2009EP1294891B1 Transport peptides derived from erns protein
05/13/2009EP1224297B1 Alzheimer's disease secretase, app substrates therefor, and uses therefor
05/13/2009EP1189920B1 Camello gene family and uses thereof
05/13/2009EP1115743B1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
05/13/2009EP1105498B1 Hiv vaccine
05/13/2009EP0914325B1 Modulators of the function of fas receptors and other proteins
05/13/2009EP0905140B9 Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use
05/13/2009EP0769551B1 Dna strand useful in increasing carotenoid yield
05/13/2009CN101432442A A sex-specific marker for shrimps and prawns
05/13/2009CN101432431A Compositions and methods for increasing plant tolerance to high population density
05/13/2009CN101432430A Plants having increased yield and a method for making the same
05/13/2009CN101432428A Recombinant human interferon-like proteins
05/13/2009CN101432302A Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibod
05/13/2009CN101432300A Vaccines and immunotherapeutics using codon optimized IL-15 and methods for using the same
05/13/2009CN101432299A House dust mite allergen
05/13/2009CN101432298A PHL P1 allergen derivative
05/13/2009CN101432297A Production of compounds in a recombinant host
05/13/2009CN101432296A Pegylated mutated clostridium botulinum toxin
05/13/2009CN101432294A Compounds analogous to growth hormone peptide secretagogues and preparations containing them
05/13/2009CN101432293A Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
05/13/2009CN101432023A Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
05/13/2009CN101432006A Method and use of lactic acid bacteria with increased acid tolerance
05/13/2009CN101429525A Antineoplastic invasion transfer function of snake venom metalloprotease inhibitors BJ46a and uses thereof
05/13/2009CN101429523A Type T non--viral vector and composite medicament containing the same
05/13/2009CN101429519A Process for producing recombinant insulin-like growth factor-1(IGF-1) amalgamation protein
05/13/2009CN101429512A Wheat PDR type ABC transfer protein gene and encoded protein thereof
05/13/2009CN101429511A Cold resistant correlated transcription factor gene of rice and uses thereof
05/13/2009CN101429510A Wheat hpfw gene, expression production and uses thereof
05/13/2009CN101429508A Process for producing ocean mussel adhesion protein water-proof biological adhesive agent
05/13/2009CN101429246A Method for producing immunoglobulins containing protection proteins and their use
05/13/2009CN101429245A Preparation of recombinant human hemoglobin with pichia stipitis
05/13/2009CN101429244A Tetracycline and carrier protein couplet product, method for producing tetracycline antibiotic antibody uses thereof
05/13/2009CN101429243A Melamine and carrier protein couplet product, preparation method and uses of melamine antibody
05/13/2009CN101429242A Gentamicin and carrier protein couplet product, method for producing gentamicin antibody and uses thereof
05/13/2009CN101429241A Penicillin and carrier protein couplet product, method for producing beta-lactam penicillin antibody, and uses thereof
05/13/2009CN101429240A Albumin containing sugar chain, preparation method and uses thereof
05/13/2009CN101429239A Anti-atherosis epitope composition, preparation method and uses thereof
05/13/2009CN101429238A Natural mycobacterium tuberculosis protein
05/13/2009CN101429237A Extraction method for escherichia coli K88, K99, 987P fimbria antigen
05/13/2009CN101429236A Type II non-structural protein 2B of dengue virus, recombinant expression vector, preparation and uses thereof
05/13/2009CN101428146A Process for producing composite injection formulation for treating esophagus cancer
05/13/2009CN101428138A Uses of Chilobrachys jingzhao toxin extract-jingzhao toxin-V in preparing pain easing medicament
05/13/2009CN100487011C Poly ethyldiol modified methyl propenoic acid glycidyl ester resin, preparation process and application thereof
05/13/2009CN100486997C Efficent polyethylene glycol activating process
05/13/2009CN100486995C Compositions and methods for WT1 specific immunotherapy
05/13/2009CN100486994C Nitrate transport protein of diatom and its coding gene and application
05/13/2009CN100486993C Evolved immunoglobulin binding molecule, and its preparation method and uses
05/13/2009CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis
05/12/2009US7531718 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
05/12/2009US7531717 Comprises nucleotide sequences coding proanthocyanidins for use as biosynthetic tools in agriculture, land reclamation animal farming and food processing
05/12/2009US7531714 Non-human transgenic animals as model study for human pathologies, being transgenic for having altered melusin expression; the non-human transgenic animals are to be used to study heart pathologies and provide therapies thereof, wherein heart pathologies are heart failure, and diluted cardiomyopathy
05/12/2009US7531648 Gene therapy
05/12/2009US7531644 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells
05/12/2009US7531642 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
05/12/2009US7531641 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531640 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
05/12/2009US7531639 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531638 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
05/12/2009US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation
05/12/2009US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure
05/12/2009US7531634 Bladder matrix protein peptides and methods of detection of bladder cancer
05/12/2009US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents
05/12/2009US7531631 Selected from calcium, magnesium, nickel, cobalt, iron or zinc ion and an acetyltriptophan or sodium caprylate stabilizer, to selectively agglutinate impurities; low speed centrifugation or ultrafiltration; genetically engineered albumin; side effect reduction
05/12/2009US7531630 Interferon-alpha polypeptides and conjugates
05/12/2009US7531629 Tumor associated antigen peptides and use of same as anti-tumor vaccines
05/12/2009US7531628 Canine CD20 compositions
05/12/2009US7531627 Protein ACA1 of Antrodia camphorata
05/12/2009US7531626 Tenebrio antifreeze proteins
05/12/2009US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders